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are not amenable to conventional extra-anatomic recon-
struction. Often, in situ aortic replacement is necessary,
potentially exposing the patient to an increased risk of
graft-related complications.
Previous reports have documented satisfactory results
with in situ reconstruction in the setting of aortic sepsis.3-9
However, most series contain a small number of patients
with limited follow-up. The purposes of this study were to
provide contemporary data on the surgical outcome of
patients treated for infected aortic aneurysms and to iden-
tify clinical variables associated with increased risk for
aneurysm-related death and vascular and graft-related com-
plications.
PATIENTS AND METHODS
We identified 6137 patients who underwent aortic
reconstruction for aneurysms of the thoracoabdominal or
abdominal aorta at the Mayo Clinic between January 1,
1976, and January 1, 2000. Forty-three patients from this
group were treated for an infected aortic aneurysm distal
to the subclavian artery, a relative incidence of 1 in 142
patients (0.7%). Primary aortic infection was defined by
(1) operative findings (inflammation and purulence), (2)
Management of infected aortic aneurysms remains
one of the most challenging clinical problems for the vas-
cular surgeon. Infected aortic aneurysms are rare and dif-
ficult to treat. They are frequently associated with
complicating factors, such as rupture, sepsis, and paravis-
ceral location, that result in increased morbidity and mor-
tality.1-2 The classic teaching for treatment of infrarenal
infected aneurysms has been aneurysm resection, soft-tis-
sue debridement, remote arterial reconstruction out of the
field of infection, and antibiotics. However, aneurysms
located in the thoracoabdominal and paravisceral aortas
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Objective: Infected aortic aneurysms are rare, difficult to treat, and associated with significant morbidity. The purpose
of this study was to review the management and results of patients with infected aortic aneurysms and identify clinical
variables associated with poor outcome.
Methods: The clinical data and early and late outcomes of 43 patients treated for infected aortic aneurysms during a 25-
year period (1976-2000) were reviewed. Variables were correlated with risk of aneurysm-related death and vascular
complications, defined as organ or limb ischemia, graft infection or occlusion, and anastomotic or recurrent aneurysm.
Results: Infected aneurysms were infrarenal in only 40% of cases. Seventy percent of patients were immunocompromised
hosts. Ninety-three percent had symptoms, and 53% had ruptured aneurysms. Surgical treatment was in situ aortic
grafting (35) and extra-anatomic bypass (6). Operative mortality was 21% (9/42). Early vascular complications
included ischemic colitis (3), anastomotic disruption (1), peripheral embolism (1), paraplegia (1), and monoparesis (1).
Late vascular complications included graft infection (2), recurrent aneurysm (2), limb ischemia (1), and limb occlusion
(1). Mean follow-up was 4.3 years. Cumulative survival rates at 1 year and 5 years were 82% and 50%, respectively, sig-
nificantly lower than survival rates for the general population (96% and 81%) and for the noninfected aortic aneurysm
cohort (91% and 69%) at same intervals. Rate of survival free of late graft-related complications was 90% at 1 year and
5 years, similar to that reported for patients who had repair of noninfected abdominal aortic aneurysms (97% and 92%).
Variables associated with increased risk of aneurysm-related death included extensive periaortic infection, female sex,
Staphylococcus aureus infection, aneurysm rupture, and suprarenal aneurysm location (P < .05). For risk of vascular
complications, extensive periaortic infection, female sex, leukocytosis, and hemodynamic instability were positively
associated (P < .05).
Conclusion: Infected aortic aneurysms have an aggressive presentation and a complicated early outcome. However, late
outcome is surprisingly favorable, with no aneurysm-related deaths and a low graft-related complication rate, similar
to standard aneurysm repair. In situ aortic grafting is a safe and durable option in most patients. (J Vasc Surg
2001;34:900-8.)
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clinical evidence of infection (fever, pain, leukocytosis),
and (3) positive aneurysm wall culture. Patients with cul-
ture-negative aneurysms were analyzed individually and
had to have convincing operative findings, fever of
unknown origin, and at least 1 week of preoperative
antibiotic treatment. Other supporting findings included
positive blood culture, positive imaging study, and patho-
logic findings such as acute, chronic, or granulomatous
inflammatory changes with bacteria, mycobacteria, or fun-
gus on special stains. Patients with aneurysms of the
ascending aorta, aortic arch, or aortic branches or pros-
thetic graft infections, and patients with positive aneurysm
wall culture but no evidence of active infection, were
excluded from the study.
Demographics, clinical characteristics, and operative
data were collected from the patients’ records.
Aneurysm location was classified10 as descending tho-
racic, thoracoabdominal, paravisceral, pararenal,
juxtarenal, and infrarenal. The choice of vascular recon-
struction was based on aneurysm location, extent of
infection, and surgeon’s preference. In general, extra-
anatomic bypass was used to treat infrarenal aneurysms
with extensive aortic and periaortic purulence. In situ
bypass was used to treat suprarenal aneurysms or
infrarenal aneurysms with minimal purulence. Early and
late medical and surgical morbidity and mortality were
recorded. Early perioperative period was defined as
occurring during the hospital stay without regard to the
number of days after the operation. Chronic renal failure
was defined as a serum creatinine level of 1.5 mg/dL or
greater and postoperative renal failure as an increase of
50% or greater in the baseline serum creatinine. Late
follow-up data were obtained from medical records,
office visits, correspondence with referring physicians,
and telephone interviews. Clinical variables were corre-
lated with early and late aneurysm-related deaths and
vascular complications, defined as organ or limb
ischemia, graft infection or occlusion, and anastomotic
or recurrent aneurysms. We attempted to ascertain
whether the complication was graft-related and whether
the problem was a direct cause of death.
Clinical characteristics. Of the 43 patients treated
for an infected aortic aneurysm, 32 were men (74%) and
11 were women. Mean age was 71 years (range, 46 to 94
years). Thirty patients (70%) had at least one comorbid
condition associated with some degree of immunosup-
pression; comorbid conditions included diabetes (33%),
chronic renal failure (30%), chronic steroid use (16%), and
chronic disease (16%), such as rheumatoid arthritis (2),
non-Hodgkin lymphoma (1), multiple myeloma (1), neu-
tropenia (1), and monoclonal gammopathy (1) (Table E I,
online only). Twenty patients (46%) had a recent infec-
tion; infections included pneumonia (6), cholecystitis (4),
urinary tract infection (4), endocarditis (3), diverticulitis
(2), soft-tissue infection (2), and osteomyelitis (1). One
patient with endocarditis had a history of infected ascend-
ing aortic aneurysm. Five patients had previous gastroin-
testinal operations in the vicinity of the aneurysm and four
had recent invasive procedures.
Forty patients (93%) were symptomatic (Table I).
Duration of symptoms before surgery was, on average, 38
days (range, 1-220 days). Twenty-three patients (53%)
had ruptured aneurysms. Of these, 9 were diagnosed pre-
operatively (6 contained and 3 free ruptures) and 14 had
contained ruptures found during the operation.
Laboratory findings included mean white blood cell count
of 12.8/mm3 (1.9-33) and sedimentation rate of 78
mm/hour (2-135).
Forty-two patients underwent preoperative imaging
studies and 34 (81%) had at least one imaging modality
consistent with the diagnosis of infected aortic aneurysm.
Fig 1. Enhanced computed tomographic scan reveals a large
paravisceral aortic aneurysm with gas bubbles and periaortic fat
stranding suggestive of infected aortic aneurysm.
Fig 2. Aortogram shows a saccular aneurysm with lobulated con-
tour in the paravisceral aorta consistent with infected aneurysm.
JOURNAL OF VASCULAR SURGERY
902 Oderich et al November 2001
Diagnostic imaging included computed tomographic scan
of the chest and/or abdomen in 39 patients (positive in
67%, Fig 1), Indium-111-labeled white blood cell scan in
12 (positive in 83%) (Fig E 1, online only), angiogram in
10 (positive in all cases, Fig 2), and magnetic resonance
angiography in four.
Bacteriology. Cultures were obtained from
aneurysm wall (42), blood (32), or bronchial washing (1).
Seventy-seven percent of patients (33/43) had at least
one positive culture (Table II). Aneurysm-wall culture was
positive in 27 cases (64%) and intraoperative Gram stain in
22 cases (52%). The culture agreement (blood and
aneurysm wall) was as follows: 16 had both positive for
the same organism, 6 had both negative, 6 had positive
blood culture and negative aneurysm-wall culture, and 2
had negative blood culture and positive aneurysm-wall
culture. One patient had blood culture positive for
Escherichia coli and aneurysm-wall culture positive for
Bacteroides fragilis. Overall, 30 patients (70%) were
receiving antibiotics preoperatively for a mean period of
20 days (range, 0-250 days). All patients with culture-
negative aneurysms were taking antibiotics.
Intraoperative findings. Aneurysms were located at
or above the renal arteries in 26 patients (60%) (Fig 3).
The mean aneurysm size was 5.9 cm (range, 3-12 cm).
Aneurysms were saccular in 29 patients (67%) and
fusiform in 14 patients (33%), without differences in clin-
ical characteristics, bacteriology, or associated comorbidi-
ties. Other findings included aneurysmal extension to iliac
arteries (9), multiple aneurysms (2), primary aortoduode-
nal fistula (2), and aortocaval fistula (1). The majority of
patients (63%) had periaortic infection with extension of
inflammation and purulence to adjacent organs, most
commonly the duodenum (11), inferior vena cava (9), left
renal vein (5), left kidney (4), left pleural cavity (3), pan-
creas (2), spleen (2), sigmoid colon (2), and stomach (1).
One patient with an infected thoracoabdominal aorta had
Staphylococcus aureus peritonitis.
Operative treatment. Of the 43 patients, 42 were
taken to the operating room and 41 underwent definitive
vascular reconstruction. The operation was classified as
emergent (12), urgent (9, within 48 hours of vascular con-
sultation), or elective (21). One patient with a ruptured
clostridial descending-thoracic aneurysm died in the emer-
gency department. One patient with multiple aneurysms
(pararenal and infrarenal) died of exsanguinating hemor-
rhage during attempt at aortic clamping. Surgical treat-
ment was in situ aortic prosthetic polyester graft
reconstruction in 35 patients (85%) and axillobifemoral
bypass in 6 patients (15%). In the in situ group, 28 patients
had straight grafts and 7 had bifurcated grafts to the iliac
(4) or femoral (3) vessels. The aortic clamp was placed at
the descending-thoracic (12), supraceliac (8), suprarenal
(4), or infrarenal aorta (17). The mean clamping time was
39.5 minutes (range, 20-87 minutes). In seven patients, a
rifampin-soaked graft was prepared by soaking a gelatin-
impregnated Dacron graft at room temperature in a 60
mg/mL solution (1200 mg rifampin powder in 20 mL
sterile saline) for between 30 minutes and 1 hour. In the
extra-anatomic bypass group, aneurysms were located in
the infrarenal (5) and juxtarenal (1) aortas. All patients
underwent extensive aortic and periaortic debridement
with excision and culture of the aneurysm wall. Additional
vascular procedures included aortorenal artery bypasses
Fig 3. Infected aortic aneurysms were distributed in the
descending-thoracic, thoracoabdominal, paravisceral, pararenal,
juxtarenal, and infrarenal aortas.
Table I. Clinical presentation and laboratory findings in
patients with infected aortic aneurysms
Variable n (N = 43) %
Symptomatic 40 93
Elevated sedimentation rate 18* 86
Fever 33 77
Pain (abdominal or back) 28 65
Leukocytosis > 12.000 23 54
Chills 22 51
Sweats 12 28
Enlarging aneurysm 12 28
Gastrointestinal symptoms† 10 25
Rupture‡ 9 21
Pulsatile mass 7 16
Hemodynamic instability 3 7
*N = 21.
†Gastrointestinal symptoms included nausea/vomiting (6) and diarrhea (5).
‡Nine patients were diagnosed preoperatively, and 14 patients with con-
tained ruptures were diagnosed during the operation.
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(3), aorto-celiac-superior mesenteric artery bypass (1),
femoral artery embolectomy (1), femoral artery interposi-
tion graft (1), and lumbar sympathectomy (1). The graft
was covered with omental flap (41%), bovine pericardium
(2%), or simple retroperitoneal closure (27%). Patients with
descending-thoracic aneurysms or with extra-anatomic
bypass had no graft coverage (30%). Nine patients had con-
comitant abdominal procedures, including cholecystec-
tomy (5), splenectomy (4), nephrectomy (3), repair of
duodenal defect (2), excision of gastric leiomyoma (1),
Hartmann procedure (1), and adrenalectomy (1). Closed-
suction drainage was used in 23 patients. Antibiotic treat-
ment was continued for life in 40% of patients (13/33) and
for 1 to 6 months in all other patients. Antibiotic duration
was based on surgeon’s preference.
Statistical analysis. Survival curves were calculated
by using the Kaplan-Meier method. Differences in survival
were determined by using the log-rank test. For analysis of
categorical variables, the χ2 and Fisher exact tests were
used. Differences between means were tested with the
Mann-Whitney test. Univariate analysis to assess the inde-
pendent effects of clinical variables on surgical outcome
was done with the Cox proportional hazards model.
Expected survival rate was calculated from life tables for
the white population of the State of Minnesota11 and for
patients who underwent repair of noninfected (ruptured
and nonruptured) aortic aneurysms at the Mayo Clinic.12
The incidence of late graft-related complications was com-
pared with that observed for patients who underwent
standard abdominal aortic aneurysm (AAA) repair.13 A 
P value of less than .05 was used to determine statistical
significance.
RESULTS
Early outcome. The operative mortality was 21%
(9/42) and was not significantly different in patients who
underwent in situ (7/35) versus extra-anatomic bypass
(1/6). Two patients (5%) died of exsanguinating hemor-
rhage in the operating room. Each patient had a ruptured
Staphylococcus aureus aneurysm, one in the descending-
thoracic aorta and the other in the pararenal aorta. One
patient (2%) with a ruptured staphylococcus coagulase-
negative paravisceral aneurysm developed an anastomotic
rupture in the proximal anastomosis of the aortic graft-
renal artery bypass. Despite graft excision and a left
nephrectomy, she died in the operating room. Although it
was suspected, there was no evidence of early graft infec-
tion in this patient. Myocardial infarction was the cause of
death in 3 patients (7%), 1 day, 5 days, and 18 days after
the operation. Two patients (5%) died of multisystemic
organ failure, one in the immediate postoperative period
(Staphylococcus aureus thoracoabdominal aneurysm), and
the other 7 days after in situ repair of a Salmonella species
paravisceral aneurysm complicated by necrotizing pancre-
atitis. One patient who presented with a nonruptured tho-
racoabdominal aneurysm died at home of unknown cause
on the twenty-fifth day after surgery.
The mean length of stay was 25 days (range, 6-119
days). Twenty-five patients (60%) had significant postop-
erative complications, including transient renal failure in 7
patients (17%) and permanent renal failure in 5 (12%), res-
piratory failure requiring prolonged ventilation in 5
patients (12%), myocardial infarction in 4 patients (10%),
pneumonia in 3 patients (7%), acute pancreatitis in 2
patients (5%), and cerebrovascular accident in 1 patient
(2%). Surgical complications occurred in 9 patients (21%),
including wound complications (3), major bleeding (1),
ischemic colitis (3), peripheral arterial embolism (1), para-
plegia (1), and permanent monoparesis (1) (Table E II,
online only).
Late outcome. The mean clinical follow-up was 4.3
years (range, 40 days to 22 years). Late follow-up was
available in all but 3 patients. Cumulative survival rates at
1 year and 5 years was 82% and 50%, respectively, signifi-
cantly lower than those observed for the general popula-
tion11 (96% and 81%) and noninfected aortic aneurysm12
cohort (91% and 69%) (Fig 4). Late deaths (18/43) were
not attributed to the initial aneurysm, but were the result
Table II. Bacteriology of infected aortic aneurysms
Culture obtained from Culture obtained from aneurysm 
Organism blood (n = 32) (74%) wall (n = 42) (98%) Total (N = 43) (%)
Culture-positive 25 (78) 27 (64) 33 (77)
Staphylococcus* 7 10 11 (26)
Escherichia coli 6 3 6 (14)
Streptococcus 4 3 5 (12)
Salmonella species 4 4 4 (9)
Listeria monocytogenes 0 1 1 (2)
Bacteroides fragilis 0 1 1 (2)
Candida 0 1 1 (2)
MAC 0 1 1 (2)
Haemophilus influenza 1 1 1 (2)
Clostridium species 1 1 1 (2)
Coccidioides immitis 1 1 1 (2)
*Staphylococcus included 6 cases of Staphylococcus aureus and 5 cases of staphylococcus coagulase-negative infection.
MAC, Mycobacterium avium complex.
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of cardiovascular causes (28%), cancer (22%), stroke
(11%), respiratory failure (11%), renal failure (6%), and
unknown etiology (22%). Rates of survival free of late vas-
cular complications were 87%, 77%, and 64% at 1 year, 5
years, and 10 years, respectively. Rate of survival free of
late graft-related complications was 90% at 1 year and 5
years, not significantly different from that observed for
patients who underwent repair of a noninfected AAA (97%
and 92%, Fig 5).13
Late vascular complications occurred in six patients
and included three graft-related complications. Two
patients developed graft infection. The first patient had
monoclonal gammopathy and a culture-negative infrarenal
aneurysm confirmed histologically to be the result of
gram-positive cocci suggestive of streptococci. His initial
operation included an axillobifemoral bypass and resection
of an incidental gastric leiomyoma. Two months later he
presented with persistent fluid collection in the right side
of the groin, which required complete graft excision and a
left axillofemoral with femorofemoral crossover graft,
despite conservative treatment with intravenous antibi-
otics and closed-suction irrigation. Subsequently, he
developed a proximal anastomotic disruption on the
twenty-second day after surgery and required a patch
angioplasty. He died 33 months later, without evidence of
graft infection at autopsy. The second patient presented
Fig 4. Kaplan-Meier survival curve for patients with infected aortic aneurysms as compared with the gen-
eral population11 and noninfected aortic aneurysm cohort.12 Survival for patients with infected aneurysms
is lower than that observed for the general population at 1 year, 5 years, and 10 years (P = .0001) and for
noninfected aortic aneurysms at 1 year and 5 years (P = .05). The survival difference between infected and
noninfected aneurysms is lost at 9 years’ follow-up.
Fig 5. Kaplan-Meier curve for late graft-related complications in patients who underwent repair of infected
aortic aneurysms versus noninfected abdominal aortic aneurysms.13 The incidence of complication is not
significantly different in either group (P > .05).
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with a Candida sp juxtarenal aneurysm associated with a
primary aortoduodenal fistula. Treatment included aortic
and periaortic debridement, primary closure of the duo-
denal defect, in situ aortobifemoral bypass, and 4 months
of antifungal therapy. Nine months after surgery, he pre-
sented with graft infection and required a right axillo-
bifemoral bypass followed by in situ graft removal. The
patient died 4 months later from a cerebrovascular acci-
dent. Finally, one patient developed a para-anastomotic
aneurysm after an in situ thoracoabdominal aneurysm
repair and died 4 years later of myocardial infarction.
Three late vascular complications were not considered
to be graft-related, including a recurrent atherosclerotic
descending-thoracic aneurysm 3 months after in situ aor-
tic grafting for infrarenal aneurysm, a remote graft occlu-
sion in a patient who had a right femoral interposition
graft used to treat a femoral pseudoaneurysm years before
his infected aortic aneurysm, and a patient who presented
with worsening peripheral vascular disease requiring
femoropopliteal bypass after in situ straight aortic grafting.
Tables III and IV summarize univariate analyses of clinical
variables associated with complicated outcome. There was
no association for type of vascular reconstruction,
immunosuppression, aneurysm morphology (saccular ver-
sus fusiform), Salmonella sp infection, use of rifampin-
soaked graft, use of omental coverage, and duration of
antibiotic treatment.
DISCUSSION
This study shows that infected aortic aneurysms com-
prise only a minority of all aneurysms (0.7%) but continue
to be challenging in several aspects. First, the diagnosis is
difficult and frequently made in late stages with fulminant
sepsis and aneurysm rupture. Second, patients are often
immunocompromised hosts, which may in part explain the
increased perioperative morbidity and mortality. Third,
infected aneurysms are more frequently located in the para-
visceral and thoracoabdominal aortas, often requiring
extensive periaortic debridement and reconstruction of vis-
ceral branches. And fourth, the ideal treatment remains
controversial, and there is special concern over whether the
type of reconstruction might contribute to an increased
incidence of graft-related complications.3-9
Contemporary series continue to report a high inci-
dence of aneurysm rupture (50%-85%) in patients with
infected aneurysms.4,6,9,14 This confirms the general belief
that the natural history of infected aneurysms is one of an
insidious febrile illness leading to early rupture and death
Table III. Univariate analysis of clinical and operative variables as risk factors for aneurysm-related death
Frequency of aneurysm-related death (%)
Variable Without With RR 95% CI P value
Positive association or trend
Extensive periaortic infection 0 (0) 10 (36) .008
Female sex 5 (16) 5 (45) 3.8 1.1-13.2 .03
Staphylococcus aureus 7 (19) 3 (50) 3.6 0.9-14 .06
Rupture 6 (18) 4 (44) 3.1 0.9-11 .08
Negative association or trend
Infrarenal location 8 (40) 2 (9) 0.2 0.04-0.9 .03
RR, Relative risk ratio; CI, confidence interval.
Table IV. Univariate analysis of clinical and operative variables as risk factors for early and/or late vascular complica-
tions
Frequency of vascular complication (%)
Variable Without With RR 95% CI P value
Positive association or trend
Extensive periaortic infection 2 (13) 16 (57) 7.4 1.7-33 .008
Female sex 10 (31) 8 (73) 3.6 1.4-9.5 .008
Leukocytosis > 16.0 13 (36) 5 (71) 3.3 1.1-9.6 .03
Hemodynamic instability 15 (38) 3 (100) 3.7 1.1-13.2 .04
Rupture 12 (35) 6 (67) 2.4 0.9-6.4 .08
Negative association or trend
Infrarenal location 12 (60) 6 (26) 0.3 0.1-0.8 .01
Infection restricted to the aorta 16 (57) 1 (8) 0.08 0.01-0.6 .01
Infrarenal clamp 12 (50) 4 (24) 0.3 0.1-1.06 .06
RR, Relative risk ratio; CI, confidence interval.
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without prompt surgical intervention. Despite the fact
that most patients are symptomatic, symptoms are usually
nonspecific (eg, fever, pain), and patients typically
undergo an extensive investigation before they are taken
to the operating room. The classic triad of fever, back
pain, and pulsatile mass, described in 40% of the patients
in previous reports,7 was found in only 16% of our
patients. The fact that these patients are often immuno-
suppressed may contribute to more aggressive infections
and early aneurysm rupture.1,4,9 In fact, 70% of our
patients had at least one chronic comorbid condition—
most commonly diabetes, renal failure, or steroid use—
that predisposes a patient to invasive or necrotizing
infections. Similarly, since the introduction of antibiotics
and effective treatment for valvular disease, the predomi-
nant organisms Streptococcus pyogenes, pneumococcus and
Enterococcus sp have become less common, and virulent
organisms more common.15,16 Staphylococcus aureus and
Salmonella sp are the dominant infecting organisms in
most recent series.4,9 Several studies on staphylococcus-
associated endocarditis have documented the aggressive
and virulent nature of this organism and Salmonella sp is
thought by many to exhibit a more virulent course
because of its ability to invade the normal intima and cause
early aneurysm rupture.16
The complicated early outcome in patients with
infected aortic aneurysms probably reflects the combina-
tion of an aggressive presentation, high rupture rate, and
complex aneurysm location in immunocompromised
hosts. With the limitations imposed by a retrospective
review and a small number of patients, we attempted to
identify variables associated with poor outcome. Extensive
periaortic infection was the one variable most significantly
associated with risk of aneurysm-related death and vascu-
lar complication. Aneurysm rupture was associated with a
positive trend, and the lack of statistical significance likely
represents a type II error caused by the small number of
patients and confounding factors. Patients with hemody-
namic instability had increased risk of vascular complica-
tions, as previously reported by Moneta and associates.6
The positive association between female sex and
increased risk of aneurysm-related death and vascular com-
plications was somewhat unexpected. The association of
female sex and increased mortality was previously reported
in patients with noninfected ruptured and nonruptured
AAAs.17,18 Noel and associates18 recently reviewed the
Mayo Clinic experience with 413 ruptured AAAs and
found a 68% mortality rate for women and a 40% rate for
men (P < .001). Women are known to have higher mor-
tality rates for coronary artery disease, cerebrovascular dis-
ease, and other types of cardiovascular surgery, notably
coronary artery bypass and heart transplantation.17,18 The
reasons for gender differences in mortality rates are
unknown, and further investigation will be required.
Repair of an infected aortic aneurysm raises concern
about risk of late complications, and published data on late
outcome are very limited in this group of patients. This
study shows that patients who leave the hospital continue
to be exposed to an increased mortality rate as compared
with the general population and noninfected aortic
aneurysm cohort. However, late mortality does not seem
to be caused by the initial infected aneurysm per se, but
rather by the natural history of associated comorbidities
and underlying atherosclerotic disease. In respect to the
risk of late graft-related complication, we found no differ-
ence in the risk when compared with standard AAA repair.
At 5 years, the incidences of any graft-related complication
and graft infection (10% and 6%, respectively) were com-
parable with those reported for standard AAA repair (8%
and 1.3%, respectively).13
Finally, is in situ aortic grafting adequate treatment for
infected aortic aneurysms? With the limitations recog-
nized, we found that in situ reconstruction is a safe and
durable option in most patients with infected aortic
aneurysms. The argument in favor of extra-anatomic
bypass is the theoretic advantage of reducing the risk of
graft infection, because revascularization is generally per-
formed in a location remote from the site of infection.
However, recent series continue to report a high incidence
of complications with extra-anatomic bypasses, including a
20% aortic stump disruption, a 20% to 29% amputation
rate, and a 20% risk of reinfection.3-7 In addition, certain
anatomic sites, such as around the aortic arch, thoracoab-
dominal aorta, and paravisceral aorta are not amenable to
conventional extra-anatomic reconstruction, and in situ
grafting is unavoidable.3,4 Furthermore, axillobifemoral
bypass followed by aneurysm excision is a challenging and
prolonged operation, which may account for the increased
mortality rate in some series. Therefore, we should re-
evaluate the classic doctrine that extra-anatomic recon-
struction is the treatment of choice for primary aortic
sepsis. Our experience8 with in situ aortic replacement in
the setting of graft infection and graft-enteric fistula
included an 8% mortality rate and a 100% 5-year limb-sal-
vage rate, significantly better than the results reported for
extra-anatomic bypasses (20% and 75%, respectively). In
the matter of graft reinfection, in situ repair did not offer
any advantage yet, with identical reinfection rates (22%) to
that reported for axillobifemoral bypass.8 It is now gener-
ally accepted that in situ aortic grafting is an appropriate
choice for most patients with primary aortic infection. The
choice of the ideal conduit is still controversial. Rifampin-
soaked grafts may prevent graft infection by reducing early
graft seeding.19 We had no reinfection when using
rifampin-soaked grafts. Other safe alternatives include
autogenous superficial femoral vein grafts20 and cryopre-
served arterial allografts.21 For patients with fulminant
sepsis, extensive aortic infection, and aortic-enteric fistula,
there is no ideal surgical option, but in situ prosthetic
grafting may represent the most expeditious method of
arterial reconstruction, with acceptable early and late mor-
bidity rates.
In summary, infected aortic aneurysms have an aggres-
sive presentation and a complicated early outcome. Late
outcome is surprisingly favorable with no aneurysm-related
deaths and a low graft-related complication rate, similar to
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the outcomes of patients who underwent standard AAA
repair. The presence of primary aortic infection should be
suspected in patients with fever, pain, leukocytosis,
immunosuppression, and a saccular aneurysm located in
unusual aortic location. Our initial diagnostic modality is a
computed tomographic scan, followed by angiogram in
stable patients with pararenal or visceral involvement. Once
the diagnosis is established or suspected, our management
algorithm includes early operation, aneurysm excision,
aneurysm wall culture, aortic and periaortic debridement,
omental coverage of the aortic graft or stump whenever
possible, and, most recently, the use of rifampin-soaked
grafts and lifelong antibiosis. We generally reserve extra-
anatomic bypass for patients with infrarenal or juxtarenal
aneurysms with extensive periaortic infection caused by vir-
ulent organisms. We feel that in situ aortic grafting is a safe
and durable option in most patients.
We are indebted to Dr Anthony Stanson and Dr
Thanila Macedo from the Department of Radiology for
help with the diagnostic imaging photographs, Mrs
Rhonda Hartmann for secretarial assistance, and Mr
Michael King for preparation of scientific illustrations.
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Dr John D. Corson (Iowa City, Iowa). The Mayo group have
provided us with some interesting data on a large 25-year series
of infected aortic aneurysms. Because of the fact that 45% of their
cases involved the aorta above the renal arteries, with 16% being
thoracoabdominal aortic aneurysms and 13% aneurysms with
involvement of the visceral arteries, in situ aortic replacement was
the surgical option in these patients. Indeed, in this series 35
patients or 85% of the group were treated in this fashion. The data
from these patients are the strength of this paper. In the manu-
script they discuss seven patients who had a rifampin-soaked
bypass graft used, but it was not clear what other types of bypass
grafts were used. In the past few years, there have been other
alternatives to conventional bypass grafts for in situ replacement,
such as aortic homografts, allografts, or the superficial femoral
vein as suggested by Clagett’s group in Dallas. What conduit
would the authors advise us to use for in situ replacements?
How long should we continue antibiotics after an in situ
replacement? Is the decision for antibiotic duration predicated on
the immunocompromised status of the patient or the organism
cultured? Interestingly, 70% of their patient population was
immunocompromised, but only 40% had long-term antibiotic
usage. However, 5% of the group had reinfection.
Finally, should we culture the walls of aortic aneurysms even
if clinically there is no hint of infection?
I would finally stress that early diagnosis is important.
Infected aortic aneurysms are prone to rupture despite not always
being of a size where conventionally we would anticipate rupture
of an atherosclerotic aortic aneurysm.
Dr Gustavo S. Oderich. Dr Corson, I would like to thank
you for your thoughtful comments.
Your first question addressed the available graft alternatives
for in situ aortic replacement. The choice of the ideal conduit is
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still controversial. As you pointed out, Dr Clagett reported his
experience with superficial femoral vein grafts in the setting of
aortic sepsis. We have had a limited experience with this tech-
nique and found that the prolonged operative time is one of the
limiting factors in critically ill patients. Another attractive option
is the use of cryopreserved arterial allografts. Some authors have
advocated the use of arterial allografts with the potential advan-
tage of reducing infection rates. We have used arterial allografts
recently in cases of aortic graft infection with favorable results.
The major limitations are availability, price, and lack of long-term
follow-up data in these patients. Finally, we favor rifampin-soaked
grafts as the conduit of choice because of its availability and
potential advantage of preventing graft infection by reducing
early graft seeding.
The second question addressed the duration of antibiotic
treatment. There are no studies comparing short versus pro-
longed antibiotic treatment in this setting. This series spanned 25
years’ experience, and there were no definitive criteria to select
duration of treatment. However, two of the three patients with
graft infection had limited antibiotics treatment. Therefore, we
have recently added to our treatment strategy the recommenda-
tion of lifelong antibiosis in the setting of primary aortic infec-
tion. Patients with virulent organisms, such as staphylococcus,
salmonella, and clostridium may represent a higher risk popula-
tion and should definitely be considered for lifelong treatment.
Dr Corson also asked about the early diagnosis of infected
aneurysms. Early diagnosis is of paramount importance as half of
these patients have either contained or free aneurysm rupture. An
infected aneurysm should be suspected in patients with symptom-
atic aortic aneurysms, fever, leukocytosis, and elevated erythro-
cyte sedimentation rate. Patients presenting with frank rupture
should be taken emergently to the operating room. For stable
patients, we currently recommend a computerized tomography
(CT) scan as the initial imaging modality. In this series, 80% of the
CT scans had findings suggestive of an infected aortic aneurysm,
including unusual aneurysm location, saccular morphology, fat
stranding, and gas bubbles. Patients with paravisceral involvement
and no evidence of rupture should probably have an arteriogram
to plan visceral reconstruction.
Dr Panneton, would you like to add any comments?
Dr Jean M. Panneton. One comment I would like to address
is aneurysm wall culture in patients without any evidence of infec-
tion, either clinically or intraoperatively. I think that it is probably
the kind of thing that you would like not to do. If you start cul-
turing aneurysm walls routinely in all your patients, you are going
to find a lot of organisms that have no clinical relevance. All the
patients included in this study had obvious clinical evidence of a
primary aortic infection as defined by imaging studies, clinical
presentation with fever, pain and leukocytosis, or intraoperative
findings such as edematous changes, purulence, periaortic
involvement, or adjacent organs destruction. I would certainly
not recommend routine aneurysm wall culture. I think in this set-
ting ignorance is bliss.
Regarding the duration of antibiotic treatment, an obvious
limitation of this study is that it is a retrospective review over a 25-
year period. I think that the recommendation for prolonged or
lifelong antibiosis 20 years ago was probably not as strong as we
currently advocate. The risk of graft infection is significant in these
patients, and I think pretty much all of us would recommend life-
long antibiosis in the setting of aortic infection. Patients with more
virulent organisms, such as Staphylococcus aureus, should definitely
receive lifelong antibiosis. I think Bactrim is a reasonable option
for antibiotic suppression in most patients. Thank you.
Dr Harry Schanzer (New York, NY). I enjoyed very much
your paper. My question is, do the bacteriological findings preop
or in any way influence what you do, and is the result of your
technique in any way related to the bacteriology?
Dr Oderich. We think that the fact that most patients were
taking antibiotics for a mean period of 25 days before the opera-
tion might have contributed to a relatively high rate of culture-
negative aneurysms. Once the diagnosis of primary aortic
infection is suspected or confirmed, we advocate some general
principles, including early operation, broad-spectrum antibiotics,
aortic and periaortic debridement, and use of rifampin-soaked
graft. We recommend in situ reconstruction for most patients and
generally reserve extra-anatomic bypass for patients with
infrarenal or juxtarenal aneurysms with extensive periaortic puru-
lence. Patients with virulent organisms should probably undergo
extraanatomic bypass.
Dr Panneton. Let me just add a comment on this. The only
case of in situ aortic grafting that eventually developed graft infec-
tion was a patient who had Candida infection and aortoduodenal
fistula. I think that if you have evidence of fungal infection, you
should perform an extra-anatomic bypass whenever possible.
Also, patients with salmonella infections may be best managed
with extra-anatomic reconstruction because of its known virulent
nature, although we had some patients with Salmonella aortitis
who successfully underwent in situ aortic replacement. Patients
with Candida infection should be treated with extra-anatomic
reconstruction.
